A case of undifferentiated connective tissue disease: is it a distinct clinical entity?

Nat Clin Pract Rheumatol. 2008 Jun;4(6):328-32. doi: 10.1038/ncprheum0799. Epub 2008 Apr 15.

Abstract

Background: In November 2001, a 24-year-old woman with thrombocytopenia and Raynaud's phenomenon presented to our clinic. Her physical examination was unremarkable except for bruising on her legs and arms.

Investigations: Laboratory assays detected the presence of antinuclear and anti-ribonucleoprotein antibodies. Tests for antibodies to double-stranded DNA and for antiphospholipid (lupus anticoagulant and anticardiolipin), anticentromere, anti-Scl-70, and antiplatelet antibodies were negative, as was a Coombs test. An echocardiogram, chest X-ray, and abdominal scan showed no abnormalities. Nailfold digital capillaroscopy revealed minor capillary changes not specific for scleroderma.

Diagnosis: Undifferentiated connective tissue disease.

Management: The patient was successfully treated initially with high doses of corticosteroids and azathioprine, followed by rapid dose tapering. Therapy was continued for 2 years and then stopped. Over the next 4 years the patient's disease history was unremarkable, apart from mild Raynaud's phenomenon of the hands and the presence antinuclear and anti-ribonucleoprotein antibodies. The diagnosis of undifferentiated connective tissue disease was confirmed at her most-recent assessment, in October 2007.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antimalarials / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Azathioprine / therapeutic use
  • Diagnosis, Differential
  • Female
  • Humans
  • Mixed Connective Tissue Disease / complications
  • Mixed Connective Tissue Disease / diagnosis*
  • Mixed Connective Tissue Disease / drug therapy
  • Pregnancy
  • Pregnancy Complications / diagnosis
  • Pregnancy Complications / drug therapy
  • Raynaud Disease / complications
  • Raynaud Disease / diagnosis*
  • Raynaud Disease / immunology
  • Remission Induction
  • Thrombocytopenia / complications*
  • Thrombocytopenia / drug therapy
  • Thrombocytopenia / immunology

Substances

  • Adrenal Cortex Hormones
  • Antimalarials
  • Antirheumatic Agents
  • Azathioprine